Gilead Sciences (GILD) Tops Q2 EPS by 35c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $129.61 --0%
EPS Growth %: -464.2%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -464.2%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.91, $0.35 better than the analyst estimate of $1.56. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.21 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Gilead Sciences (GILD) to Buy
- Melius Upgrades Allegiant Travel Company (ALGT) to Buy
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
